BBC vs PCI

Virtus LifeSci Biotech Clinical Trials ETF

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

PIMCO Dynamic Credit and Mortgage Income Fund

PIMCO Dynamic Credit and Mortgage Income Fund is a closed end fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in fixed income markets across the globe. The fund utilizes a dynamic asset allocation approach and seeks to invest in multiple fixed-income sectors in the global credit markets, including corporate debt, mortgage-related and other asset-backed securities, government and sovereign debt, taxable municipal bonds and other fixed, variable and floating rate income producing securities. It benchmarks the performance of its portfolio against a combined benchmark comprised of 80% Barclays Investment Grade Index and 20% BofA High Yield Index. The fund was formerly known as PIMCO Dynamic Credit Income Fund. PIMCO Dynamic Credit and Mortgage Income Fund was formed on January 31, 2013 and is domiciled in the United States.